Bringing the fundamentals into focus…
Back to Vir Biotechnology, Inc.
How Vir Biotechnology, Inc. stacks up
VIR · against 382 other Healthcare companies of similar size
Growth
86/ 100
Near the top of its peers.
Ranked #51 of 383 · scores higher than 86% of peers
Bars: peers in each 10-point band of the growth score43 peers with a growth score of 80–89, including VIR · Click a bar to see the companies
Why growth scores 86?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, which is stronger than most Healthcare peers.
- slower revenue growth over three years: weaker than 92% of peers. 3-year revenue growth: -14.8% vs peer median 5.8%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 99% of peers. Revenue growth: 1495.9% vs peer median 6.1%
Metric by metric
Position: dot = VIR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VIR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 384 reported | 1495.9% | 6.2% | 98% | 33% | |
| Earnings per share growthHigher is better · 216 reported | Not reported | 8.1% | — | — | 33% |
| 3-year revenue growthHigher is better · 375 reported | -14.8% | 7.2% | 8% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around VIR| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 51 | 12.3B CNY (≈$1.7B) | 86 | 85 | |
| 51 | 2.3B USD | 86 | 74 | |
| 51 | 1.1B EUR (≈$1.2B) | 86 | 72 | |
| 51 | 1.5B EUR (≈$1.6B) | 86 | 44 | |
| 51 | 1.9B USD | 86 | 42 | |
| 56 | 8.8B CNY (≈$1.2B) | 85 | 54 | |
| 56 | 158.6B INR (≈$1.9B) | 85 | 70 | |
| 56 | 1.9B USD | 85 | 47 | |
| 59 | 23.0B CNY (≈$3.2B) | 84 | 64 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score